Company / Capital Returned to Shareholders
Steris Capital Returned to Shareholders History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$431.2M
FY2024
5-year range
$212.3M / $492.1M
FY2020-FY2024
Trend
+103.1%
vs FY2023
Sector context
#37 of 103
Health Care
What the data says
At $431M, Steris's capital returned to shareholders ranks #37 of 103 in the Health Care sector. Capital Returned to Shareholders has fluctuated over the past 8 years, ranging from $148M in FY2020 to $492M in FY2022.
Based on SEC 10-K filings.
$431M in FY2024 with a 5-year CAGR of +19.9%.
Declined from $492M to $431M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +25.3%
- 5-Year CAGR
- +19.9%
- 10-Year CAGR
- -
Sector benchmark
#37 of 103 in Health CareTop 36% of 103This company $431.2M Sector average $721.8M
▼
-40.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +19.9%, indicating consistent growth.
- In FY2024, capital returned to shareholders increased 103.1% year-over-year.
- Ranks #37 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $431.2M | +103.1% |
| FY2023 | $212.3M | -56.8% |
| FY2022 | $492.1M | +124.7% |
| FY2021 | $218.9M | +47.5% |
| FY2020 | $148.5M | -14.8% |
| FY2019 | $174.3M | -10.2% |
| FY2018 | $194.0M | - |
| FY2017 | - | - |
| FY2016 | $190.7M | - |
As of FY2024 · SEC 10-K · Updated Mar 13, 2026